Shanik Gupta

Shanik Gupta, an Assistant Professor of Pathology at Mayo Clinic and expert in urologic pathology, discusses the groundbreaking role of molecular testing in solid tumors. She highlights its significance in classifying tumors, especially kidney cancer, and how recent advancements have changed treatment options. Gupta delves into the challenges of keeping up with rapid innovations in molecular knowledge and emphasizes the value of interdisciplinary collaboration. She also shares her thoughts on the future of testing and the necessity for standardized protocols in hereditary oncology.